GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Optimus Healthcare Services OHCS · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

At a glance

Figures in USD, from our data supplier.

FY2024

Revenue

$1.5m

FY2015FY2024

Net income

−$11.1m

FY2015FY2024

Free cash flow

−$3.7m

FY2015FY2024

Shareholders' equity

−$7.1m

FY2015FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Revenue$1.5m$1.5m$1.2m$827,266$1.1m$729,676$4.4m$7.0m$5.8m$1.7m
Operating income−$8.6m−$8.6m−$8.1m−$7.7m−$382,000−$708,000$737,060$615,400−$307,000−$253,000
Net income−$11.1m−$11.1m−$10.7m−$7.8m−$150,000−$723,000$4.4m$478,451−$494,000−$320,000
Diluted earnings per share-0.23-0.28-0.28-0.46-0.02-0.090.550.06-0.06-0.01

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Total assets$1.1m$1.1m$2.9m$7.8m$2.0m$756,907$5.3m$2.8m$1.8m$1.2m
Cash and short-term investments$100,319$100,319$895,216$1.6m$1.0m$113$4.9m$884,265$601,879$195,400
Total liabilities$8.2m$8.2m$4.6m$2.4m$1.5m$958,974$1.5m$3.4m$2.5m$1.6m
Debt$6.0m$6.0m$3.3m$1.2m$619,875$233,140—$2.1m$2.1m$1.5m
Shareholders' equity−$7.1m−$7.1m−$1.6m$5.4m$719,366−$202,067$3.8m−$654,736−$747,972−$376,691
Shares outstanding48m40m38m17m8m8m8m8m8m48m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash from operations−$3.7m−$3.7m−$4.0m−$2.8m−$258,135$8,017−$667,016$508,049−$38,759−$117,832
Capital spending−$35,431−$35,431−$57,540−$316,653−$4−$5,061—−$1,934−$162,747−$349,519
Free cash flow−$3.7m−$3.7m−$4.1m−$3.1m−$258,139$2,956−$667,016$506,115−$201,506−$467,351
Dividends paid————————−$54,354—

Latest quarters

By quarter end

Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022
Revenue$384,763$639,303$344,465$450,006$453,717$322,414$271,642$217,937
Operating income−$1.6m−$1.2m$512,490−$2.1m−$1.3m−$2.4m−$2.7m−$1.6m
Net income−$1.8m−$1.5m−$423,000−$3.5m−$1.8m−$2.9m−$3.0m−$3.8m
Diluted earnings per share-0.04-0.03-0.01-0.09-0.04-0.07-0.07-0.10
Cash from operations—————−$1.0m−$1.0m−$1.0m
Total assets$629,520$863,067$820,124$1.1m$2.3m$2.1m$2.6m$2.9m
Cash and short-term investments$152,357$12,764$71,572—$200,368$197,121$476,598$895,216
Debt$6.7m$6.6m$6.4m$1,592$5.5m$4.5m$3.3m$3.0m
Shareholders' equity−$9.3m−$8.7m−$8.2m−$7.1m−$5.2m−$4.3m−$2.5m−$1.6m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue21.9%15.5%5.0%
Operating income3.5%64.7%45.3%
Net income12.7%72.7%49.1%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-572.3%-653.5%-496.4%-124.9%
Net margin-741.1%-806.8%-605.9%-140.6%

Valuation history

At each fiscal year end

FY2024
Price to sales0.0

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-16%328%-9%294%891%333239%-80%-23%-31%-24%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 1 Mar 2019.

FY2019
Paid in the year0.00
  • 5000-to-1 reverse split · 14 Mar 2013
  • 3000-to-1 reverse split · 7 Sept 2011
  • 3000-to-1 reverse split · 10 Nov 2010
  • 500-to-1 reverse split · 7 May 2010
  • 20-to-1 reverse split · 10 Aug 2009

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.